Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,963 | 92,490 | 102,582 | 271,218 | 229,592 |
| Marketable Securities | 77,030 | 77,417 | 87,171 | 151,232 | 181,747 |
| Receivables | 67,414 | 95,411 | 82,282 | 70,583 | 82,043 |
| Inventories | 72,397 | 74,912 | 55,784 | 55,044 | 56,505 |
| Other current assets | 2,350 | 2,416 | 2,392 | 2,433 | 2,539 |
| TOTAL | $307,319 | $345,486 | $332,422 | $552,517 | $554,640 |
| Non-Current Assets | |||||
| PPE Net | 29,936 | 28,003 | 27,314 | 26,099 | 26,162 |
| Investments And Advances | 178,952 | 175,865 | 193,732 | 153,853 | 174,841 |
| Intangibles | 425,702 | 435,431 | 439,632 | 220,318 | 234,272 |
| Other Non-Current Assets | 49,982 | 52,829 | 50,547 | 48,008 | 49,761 |
| TOTAL | $684,572 | $692,128 | $711,225 | $448,278 | $485,036 |
| Total Assets | $991,891 | $1,037,614 | $1,043,647 | $1,000,795 | $1,039,676 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 26,662 | 36,328 | 35,149 | 38,192 | 51,770 |
| Accounts payable and accrued liabilities | 65,309 | 76,792 | 66,127 | 45,385 | 44,512 |
| Other current liabilities | 1,989 | 2,040 | 1,917 | 33,040 | 1,291 |
| TOTAL | $105,302 | $132,553 | $117,773 | $135,945 | $114,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,265 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 19,516 | 11,456 | 12,366 | 12,995 | 15,216 |
| TOTAL | $44,571 | $32,464 | $36,434 | $35,375 | $39,375 |
| Total Liabilities | $149,873 | $165,017 | $154,207 | $171,320 | $153,435 |
| Shareholders' Equity | |||||
| Common Shares | 628,854 | 652,681 | 668,425 | 641,461 | 694,351 |
| Retained earnings | 191,647 | 199,531 | 207,645 | 181,207 | 174,545 |
| Other shareholders' equity | -259 | -1,085 | -7,712 | -12,435 | -1,386 |
| TOTAL | $842,018 | $872,597 | $889,440 | $829,475 | $886,241 |
| Total Liabilities And Equity | $991,891 | $1,037,614 | $1,043,647 | $1,000,795 | $1,039,676 |